tiprankstipranks
Trending News
More News >
MedPeer, Inc. (JP:6095)
:6095
Japanese Market
Advertisement

MedPeer, Inc. (6095) AI Stock Analysis

Compare
0 Followers

Top Page

JP:6095

MedPeer, Inc.

(6095)

Rating:74Outperform
Price Target:
¥783.00
▲(12.18%Upside)
The stock's overall performance is bolstered by strong financial health and attractive valuation. However, the technical indicators suggest bearish momentum that could impact short-term price movements. The absence of new guidance or significant corporate events means these factors do not contribute to the overall assessment.

MedPeer, Inc. (6095) vs. iShares MSCI Japan ETF (EWJ)

MedPeer, Inc. Business Overview & Revenue Model

Company DescriptionMedPeer, Inc. (6095) is a Japanese healthcare technology company that operates a medical platform designed to facilitate information exchange and collaboration among healthcare professionals. The company primarily operates in the digital healthcare sector, offering services such as a peer-to-peer network for doctors, which allows them to share experiences and insights on medical cases and treatments. MedPeer also provides health-related information and services to patients and the broader public.
How the Company Makes MoneyMedPeer, Inc. generates revenue through multiple channels, primarily focusing on subscription and advertising models. The company's platform offers premium subscription services to healthcare professionals who seek access to exclusive content, detailed medical case studies, and advanced networking tools. Additionally, MedPeer earns revenue from advertising by partnering with pharmaceutical companies and other healthcare-related businesses to promote products and services on their platform. These partnerships allow MedPeer to leverage its professional network to provide targeted advertising solutions. Furthermore, the company may generate income through sponsored content and collaborations with medical institutions for research and development projects.

MedPeer, Inc. Financial Statement Overview

Summary
MedPeer, Inc. exhibits solid financial performance with strong revenue and profit growth, efficient cost management, and low leverage. The income statement and balance sheet reflect overall financial health. However, cash flow management needs attention to support long-term growth and operational resilience.
Income Statement
85
Very Positive
MedPeer, Inc. demonstrates strong revenue growth with a notable increase from 2022 to TTM 2024. The gross profit margin is robust, indicating efficient cost management. While the net profit margin is healthy, the slight decline in EBIT margin suggests increasing operational expenses. Overall, the income statement reflects a solid financial performance with room for margin improvement.
Balance Sheet
80
Positive
The balance sheet is strong with a low debt-to-equity ratio, indicating financial stability and low leverage risk. The equity ratio highlights a solid asset base supported by equity. Return on Equity (ROE) is commendable, showing efficient use of shareholder funds. However, the slight increase in total liabilities requires monitoring to ensure continued financial health.
Cash Flow
70
Positive
Cash flow analysis shows mixed results. The operating cash flow has significantly increased, demonstrating enhanced cash-generating capability. Free cash flow has grown, but the absence of recent data limits a complete trend analysis. The ratio of operating cash flow to net income is favorable, suggesting good cash conversion. Continued focus on sustaining cash flow growth is necessary.
BreakdownSep 2024Sep 2023Sep 2022Sep 2021Sep 2020
Income Statement
Total Revenue14.95B14.54B8.45B7.44B5.31B
Gross Profit6.87B6.87B5.03B4.85B3.51B
EBITDA3.01B1.87B1.30B1.98B1.27B
Net Income1.48B617.68M812.39M1.29B725.97M
Balance Sheet
Total Assets15.55B15.16B9.35B8.54B7.13B
Cash, Cash Equivalents and Short-Term Investments7.28B5.39B6.14B5.70B4.70B
Total Debt3.16B3.81B179.12M136.32M202.90M
Total Liabilities6.10B6.57B1.49B1.56B1.55B
Stockholders Equity9.45B8.30B7.59B6.71B5.35B
Cash Flow
Free Cash Flow1.63B494.10M691.01M1.11B758.87M
Operating Cash Flow1.89B600.07M853.23M1.36B930.30M
Investing Cash Flow1.27B-5.01B-422.88M-345.39M-469.23M
Financing Cash Flow-1.27B3.67B7.08M-15.44M1.11B

MedPeer, Inc. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price698.00
Price Trends
50DMA
739.58
Negative
100DMA
598.00
Positive
200DMA
551.75
Positive
Market Momentum
MACD
6.10
Positive
RSI
37.81
Neutral
STOCH
33.33
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6095, the sentiment is Negative. The current price of 698 is below the 20-day moving average (MA) of 760.05, below the 50-day MA of 739.58, and above the 200-day MA of 551.75, indicating a neutral trend. The MACD of 6.10 indicates Positive momentum. The RSI at 37.81 is Neutral, neither overbought nor oversold. The STOCH value of 33.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:6095.

MedPeer, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (52)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
¥19.11B17.44
2.13%12.51%9.68%
74
Outperform
¥15.36B8.87
0.64%-12.13%291.07%
73
Outperform
¥11.62B23.26
2.58%9.21%-20.04%
72
Outperform
¥20.87B21.30
1.45%17.20%20.25%
52
Neutral
$7.63B0.11-62.96%2.08%16.16%0.31%
45
Neutral
¥13.81B
-79.38%-1239.83%
43
Neutral
¥20.16B4,465.71
1.26%-7.98%-181.00%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:6095
MedPeer, Inc.
698.00
71.82
11.47%
JP:3649
FINDEX Inc.
752.00
-316.56
-29.62%
JP:3902
Medical Data Vision Co.Ltd.
514.00
-28.53
-5.26%
JP:3939
Kanamic Network Co., LTD.
447.00
-104.34
-18.92%
JP:4263
SUSMED,Inc.
821.00
257.00
45.57%
JP:4320
CE Holdings Co., Ltd.
698.00
150.16
27.41%

MedPeer, Inc. Corporate Events

MedPeer, Inc. Announces Amendments to MBO and Tender Offer Recommendations
Jul 24, 2025

MedPeer, Inc. has announced amendments to its previously issued notices regarding a Management Buyout (MBO) and a recommendation to tender shares. The company has resolved to support the tender offer initiated by NMT, Inc., which includes extending the tender offer period to provide shareholders with more time to decide. This decision is aimed at enhancing corporate value and ensuring fairness in the transaction, reflecting MedPeer’s commitment to its shareholders and corporate governance.

MedPeer Extends Tender Offer Period Amid Stable Share Price
Jul 24, 2025

MedPeer, Inc. announced an extension of the tender offer period by NMT, Inc. for its share certificates, now totaling 60 business days. The tender offer price remains unchanged at 700 yen per share, and no insider information affecting investor decisions has been reported. The settlement date is set for August 15, 2025, and the company has clarified that shares not tendered will be acquired by the Tender Offeror if the offer is successful.

MedPeer, Inc. Announces Extension of NMT, Inc.’s Tender Offer
Jul 24, 2025

MedPeer, Inc. has announced an amendment to the ongoing tender offer by NMT, Inc. for its shares. The tender offer, which began on May 15, 2025, has been extended to August 7, 2025, to provide shareholders more time to consider their participation. This extension aims to increase the likelihood of completing the tender offer, impacting MedPeer’s shareholder dynamics and potentially its market positioning.

MedPeer, Inc. Announces Extension of NMT, Inc.’s Tender Offer Period
Jul 9, 2025

MedPeer, Inc. has announced an amendment to the ongoing tender offer by NMT, Inc. for its share certificates. The tender offer period has been extended by 10 business days, now concluding on July 24, 2025, to provide shareholders additional time to consider their options. This move aims to enhance the likelihood of the tender offer’s completion, reflecting a strategic effort by NMT, Inc. to secure its acquisition of MedPeer, Inc.

MedPeer, Inc. Extends Tender Offer Period Amid MBO Amendments
Jul 9, 2025

MedPeer, Inc. announced amendments to its previously released notice concerning a Management Buyout (MBO) and a recommendation to tender, involving an extension of the tender offer period by NMT, Inc. The extension aims to provide shareholders with more time to consider tendering their shares, potentially impacting the company’s shareholder structure and market presence.

MedPeer, Inc. Extends Tender Offer Period Amid MBO Amendments
Jun 25, 2025

MedPeer, Inc. announced amendments to its previously declared management buyout (MBO) and tender offer process, initiated by NMT, Inc., aimed at delisting MedPeer’s shares. The tender offer period has been extended to provide shareholders more time to decide on tendering their shares, with the period now concluding on July 9, 2025. This strategic move is intended to increase the likelihood of a successful tender offer, although the tender price remains unchanged for now.

MedPeer, Inc. Extends Tender Offer Period Amid NMT Acquisition Bid
Jun 25, 2025

MedPeer, Inc. has announced an amendment to the ongoing tender offer by NMT, Inc. for its share certificates. The tender offer period has been extended by 10 business days, now concluding on July 9, 2025, to give shareholders more time to consider their participation. This extension aims to increase the likelihood of the tender offer’s completion, although the tender offer price remains unchanged for now.

MedPeer Announces Amendments to MBO Tender Offer Notice
May 15, 2025

MedPeer, Inc. announced amendments to its previously published notice regarding the implementation of a Management Buyout (MBO) and a recommendation to tender shares. The amendments clarify the intentions of Mr. Yo Iwami, a significant shareholder, to release collateralized shares and participate in the tender offer. The company plans to finance the tender offer through a bank loan from MUFG Bank and an equity investment, with the acquired shares and certain company assets pledged as collateral.

MedPeer, Inc. Announces Management Buyout and Delisting Plans
May 14, 2025

MedPeer, Inc. has announced a management buyout (MBO) involving a tender offer by NMT, Inc. to purchase its common shares, with the intention of taking the company private and delisting its shares. The board has expressed support for the tender offer, recommending shareholders to tender their shares, while leaving stock acquisition rights holders to decide independently. This move is expected to retract MedPeer’s plan for compliance with continued listing criteria, impacting its market presence and shareholder dynamics.

NMT, Inc. Launches Tender Offer for MedPeer, Inc. Shares
May 14, 2025

NMT, Inc. has announced a tender offer to acquire all shares of MedPeer, Inc., aiming to delist the company from the Tokyo Stock Exchange. This move, characterized as a management buyout, will see NMT’s founder, Yo Iwami, maintaining involvement in MedPeer’s operations, potentially impacting stakeholders by consolidating control and potentially reshaping the company’s strategic direction.

MedPeer, Inc. Reports Decline in Financial Results Amidst Market Challenges
May 14, 2025

MedPeer, Inc. reported a decline in its consolidated financial results for the six months ended March 31, 2025, with net sales and operating profits experiencing significant decreases compared to the previous year. Despite the downturn in sales, the company saw a substantial increase in profit attributable to owners of the parent, indicating improved efficiency or cost management. The forecast for the fiscal year ending September 30, 2025, suggests further declines in sales and profits, posing challenges for the company’s future growth and market positioning.

MedPeer, Inc. Supports Tender Offer and Plans Delisting
May 14, 2025

MedPeer, Inc. has announced its support for a tender offer by NMT, Inc. to purchase its common stock and stock acquisition rights, with plans to delist the company shares following the offer. This decision leads to the retraction of MedPeer’s previously announced compliance plan for continued listing criteria, indicating a strategic shift in the company’s market approach and potential implications for its shareholders.

MedPeer Revises Dividend Forecast Amid Tender Offer Plans
May 14, 2025

MedPeer, Inc. announced a revision to its dividend forecast for the fiscal year ending September 2025, deciding not to distribute year-end dividends. This decision aligns with the company’s support for a tender offer by NMT, Inc., which aims to take MedPeer private and delist its shares. The tender offer price assumes no year-end dividends, reflecting a strategic shift in the company’s financial planning and shareholder returns policy.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 26, 2025